APA (7th ed.) Citation

Saffari, A., Brösse, I., Tilburg, C. M. v., Hoffmann, G. F., Kölker, S., Witt, O., . . . Syrbe, S. (2019). Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age - a multicenter retrospective study. Orphanet journal of rare diseases, 14, . https://doi.org/10.1186/s13023-019-1077-6

Chicago Style (17th ed.) Citation

Saffari, Afshin, Ines Brösse, Cornelis M. van Tilburg, Georg F. Hoffmann, Stefan Kölker, Olaf Witt, Till Milde, Andreas Ziegler, and Steffen Syrbe. "Safety and Efficacy of MTOR Inhibitor Treatment in Patients with Tuberous Sclerosis Complex Under 2 years of Age - a Multicenter Retrospective Study." Orphanet Journal of Rare Diseases 14 (2019). https://doi.org/10.1186/s13023-019-1077-6.

MLA (9th ed.) Citation

Saffari, Afshin, et al. "Safety and Efficacy of MTOR Inhibitor Treatment in Patients with Tuberous Sclerosis Complex Under 2 years of Age - a Multicenter Retrospective Study." Orphanet Journal of Rare Diseases, vol. 14, 2019, https://doi.org/10.1186/s13023-019-1077-6.